4 results match your criteria: "Li Ka Shing Centre Robinson Way[Affiliation]"
Immunol Cell Biol
August 2024
Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre Robinson Way, Cambridge, UK.
In this article, I aim to give some pieces of career advise for young immunologists based on my own experiences.
View Article and Find Full Text PDFPLoS Genet
January 2020
Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Victoria Street Darlinghurst Sydney, NSW, Australia.
Acquired resistance to endocrine therapy is responsible for half of the therapeutic failures in the treatment of breast cancer. Recent findings have implicated increased expression of the ETS transcription factor ELF5 as a potential modulator of estrogen action and driver of endocrine resistance, and here we provide the first insight into the mechanisms by which ELF5 modulates estrogen sensitivity. Using chromatin immunoprecipitation sequencing we found that ELF5 binding overlapped with FOXA1 and ER at super enhancers, enhancers and promoters, and when elevated, caused FOXA1 and ER to bind to new regions of the genome, in a pattern that replicated the alterations to the ER/FOXA1 cistrome caused by the acquisition of resistance to endocrine therapy.
View Article and Find Full Text PDFFood Energy Secur
February 2018
Plant Sciences Department Rothamsted Research Harpenden Hertfordshire UK.
A detailed network describing asparagine metabolism in plants was constructed using published data from Arabidopsis () maize (), wheat (), pea (), soybean (), lupin (), and other species, including animals. Asparagine synthesis and degradation is a major part of amino acid and nitrogen metabolism in plants. The complexity of its metabolism, including limiting and regulatory factors, was represented in a logical sequence in a pathway diagram built using yED graph editor software.
View Article and Find Full Text PDFNeoplasia
September 2015
Institute of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1QH, UK. Electronic address:
Cellular senescence is a barrier to tumorigenesis in normal cells, and tumor cells undergo senescence responses to genotoxic stimuli, which is a potential target phenotype for cancer therapy. However, in this setting, mixed-mode responses are common with apoptosis the dominant effect. Hence, more selective senescence inducers are required.
View Article and Find Full Text PDF